http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201400117-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 |
| filingDate | 2013-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01970af7f24494eab91abce0f2359373 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fbf97abfda406904c3191ab1e0395b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0da35f4b4303aae4dfc15407b0ce96c7 |
| publicationDate | 2014-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201400117-A |
| titleOfInvention | Treatment of ocular inflammation with laquinimod |
| abstract | The present invention discloses a method of treating an ocular inflammatory disease (OID), such as uveitis or conjunctivitis, comprising periodically administering a therapeutically effective amount of laquinimod or a pharmaceutically acceptable salt thereof. The invention also provides a pharmaceutical composition comprising laquinimod or a pharmaceutically acceptable salt thereof for treating OID, uveitis, bacterial conjunctivitis, viral conjunctivitis, eyelid tissue, lacrimal, Individuals with eyelids, cornea, retina, or inflamed vision. The present application also provides a method of treating an individual suffering from an autoimmune disease-associated ocular inflammation comprising administering to a subject a therapeutically effective amount of laquinimod or a pharmaceutically acceptable salt to the subject, and providing a An ophthalmic pharmaceutical composition comprising laquinimod or a pharmaceutically acceptable salt thereof for use in the treatment of autoimmune disease-associated ocular inflammation. |
| priorityDate | 2012-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.